Molecular and cellular markers for measurable residual disease in acute lymphoblastic leukemia
Acute leukemia is the leading cause of death in children worldwide, particularly in developing countries where the growing number of cases with unfavorable prognosis and high risk of early relapse have positioned pediatric cancer as a priority. The late and imprecise diagnosis, malnutrition and unfa...
Saved in:
Main Authors: | Gerardo Juárez-Avendaño (Author), Nereida Méndez-Ramírez (Author), Nuria C. Luna-Silva (Author), David Gómez-Almaguer (Author), Rosana Pelayo (Author), Juan C. Balandrán (Author) |
---|---|
Format: | Book |
Published: |
Permanyer,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Minimal Residual Disease Detection in Pediatric Acute Lymphoblastic Leukemia
by: Miyoung Kim, et al.
Published: (2020) -
Hematrack: High sensitivity measurable residual disease (MRD) monitoring in acute lymphoblastic leukemia with NGS
by: Vineeth Surendranath, et al.
Published: (2024) -
Assessing the impact of steroid responsiveness in the era of measurable residual disease-based management in acute lymphoblastic leukemia
by: Maddukuri Sriram, et al.
Published: (2024) -
Clinical profile and outcome of impact of minimal residual assessment on outcomes in a cohort of patients with acute lymphoblastic leukemia
by: Shreyasi Das, et al.
Published: (2022) -
Treatment of acute lymphoblastic leukemia with protocol Hongkong-Indonesia Acute Lymphoblastic Leukemia 97
by: Johannes Bondan Lukito
Published: (2007)